MediPharm Labs Appoints New CFO

Bobby Kwon joins MediPharm Labs as their new CFO, to begin in two weeks time.

MediPharm Labs Corp. (TSX: LABS) a global leader in specialized, research-driven cannabis extraction, distillation and purification, is pleased to announce Robert (Bobby) Kwon will join MediPharm Labs as Chief Financial Officer (CFO), effective November 18, 2019. Christopher Hobbs, the Company's current CFO will continue to serve on the Board of MediPharm Labs.

Bobby Kwon brings over 25 years of international experience in the consumer-packaged goods, retail and pharmaceutical industries; holding senior roles in finance, strategic planning, and operations working in Canada, U.S., the Netherlands, and U.K.  Most recently, Bobby served as the Senior Vice President of George Weston Ltd. (Weston Group), Canada's largest food and drug retail business. He was a trusted and strategic advisor to Weston Group's owner and Executive Chairman on key activities and transformational transactions including the $12 billion acquisition of Shoppers Drug Mart. Prior to Weston Group, Bobby held a number of senior finance and corporate roles at Unilever including Chief Financial Officer, Canada. During his tenure at Unilever, Bobby co-led enterprise strategic planning across global business units and was an instrumental member closely involved in various corporate development transactions including Unilever's $4 billion acquisition of Alberto Culver, a large global hair and skin products manufacturer, and a partnership between PepsiCo and Lipton Ready to Drink Tea, owned by Unilever.  Additionally, Bobby was a core member of "One Unilever", a global transformation initiative focused on unlocking $1 billion in savings.  Previously, Bobby was Director of Finance at Janssen-Ortho Inc. partnering with operations and corporate development functions.

On behalf of the Board, we are thrilled to welcome Bobby to MediPharm Labs' strong management team, where he will undoubtedly have a positive impact at all levels of the organization as we move forward through our next phase of global growth. Pat McCutcheon, Chief Executive Officer, MediPharm Labs. 

McCutcheon went on to say that "as a proven finance leader with a distinguished track record, Bobby's strategic vision, creativity and broader leadership and operational expertise will bring valuable new perspectives to our business and financial strategies as we advance our platform and seize opportunities in this rapidly growing global industry."

"I am excited to be joining the pioneering team at MediPharm Labs as the Company embarks on its next phase of global expansion," said Bobby Kwon. "I believe the potential for growth and value creation is tremendous as the Company is uniquely positioned to capitalize on the opportunities ahead in this fast moving and dynamic sector. I look forward to working with MediPharm Labs' leadership team and employees to help drive the Company forward as innovation leaders."

Pat McCutcheon added, "I'd also like to thank Chris Hobbs for his many contributions and leadership as CFO. We look forward to his continued guidance as a member of the Board."

Bobby holds an MBA from Queen's University, a B.Sc. in Biochemistry from University of Toronto and is a Chartered Professional Accountant. He currently serves on the Boards of CPA Ontario and Canadian Commercial Corporation (Federal Crown). 

In connection with Bobby's appointment as CFO, the Company granted 600,000 stock options to him as at the close of business on November 1, 2019. Each grant has a five-year term expiring November 1, 2024, and vests in five equal instalments, the first of which vests immediately with the four other instalments vesting on the dates which are six, twelve, eighteen and twenty-four months from the grant date. The stock options are subject to any necessary regulatory approvals.

To learn more about MediPharm Labs visit their company HQ here.

Disclaimer: Past performance is not an indicator of future performance.

Disclaimer: past performance is not an indicator of future performance

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Louis O'Neill
Louis O'Neill

Louis is a writer based in Sydney with a focus on social and political issues. Having interviewed local politicians and entrepreneurs, Louis now focuses on cannabis culture, legislation & reform.

Leave a Reply

Your email address will not be published. Required fields are marked *